Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Clinical trial NCT01118234 · COMPLETED

Trial details

NCT number: NCT01118234
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2009-12-01
Primary completion: 2018-02-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.